Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00760409 · ClinicalTrials.gov registry record
Differentiating Recurrent Brain Tumor Versus Radiation Injury Using MRI
A clinical trial, sponsored by University of Michigan.
- Completed
- Registry status
- 28
- Enrollment target
NCT00760409: Completed study, sponsored by University of Michigan.
NCT00760409 is a clinical trial that has completed, run by University of Michigan. The registered enrollment target is 28 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00760409 has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- 28 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if certain MRI imaging sequences (pictures) are more helpful to the physicians in determining if a brain tumor has recurred or if the person has radiation injury following their treatment.
Primary Outcome
The purpose of this study is to determine if certain MRI imaging sequences are more helpful to the physicians in determining if the tumor has come back or if it is radiation injury
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2008-09 |
| Est. Completion | 2015-06-01 |
What the finished NCT00760409 record still lists
NCT00760409 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 28 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00760409 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00760409 about?
NCT00760409 is a clinical study titled "Differentiating Recurrent Brain Tumor Versus Radiation Injury Using MRI". The purpose of this study is to determine if certain MRI imaging sequences (pictures) are more helpful to the physicians in determining if a brain tumor has recurred or if the person has radiation injury following their treatment.
What is the current status of trial NCT00760409?
This trial is currently completed. The enrollment target is 28 participants. The study started on 2008-09. Estimated completion is 2015-06-01.
Who is sponsoring clinical trial NCT00760409?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia